Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 2.75 (3.01%)
Data as of 03/19/19 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $94.01 with a 52 week high of $98.37 and a 52 week low of $55.18.
Recent News
02/12/19iRhythm Technologies Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial OutlookPrinter Friendly Version
01/29/19iRhythm Technologies to Report Fourth Quarter and Full Year 2018 Financial Results on February 12, 2019Printer Friendly Version
01/07/19Research Published in Nature Medicine Demonstrates the Promise of Algorithm-Based Ambulatory Cardiac MonitoringPrinter Friendly Version
Upcoming Events
There are currently no events scheduled.